First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial.

Kaufmann, M

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: results of the MONICA trial. [electronic resource] - European journal of cancer (Oxford, England : 1990) Dec 2010 - 3184-91 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1879-0852

10.1016/j.ejca.2010.07.009 doi


Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--administration & dosage
Breast Neoplasms--drug therapy
Breast Neoplasms, Male--drug therapy
Capecitabine
Deoxycytidine--administration & dosage
Disease Progression
Disease-Free Survival
Female
Fluorouracil--administration & dosage
Humans
Male
Middle Aged
Neoplasm Metastasis
Prospective Studies
Quality of Life